Read More Pharma Industry News Avacta Group progresses to final cohort in Phase 1a study of AVA6000 Avacta Group plc (AIM: AVCT), a leader in the life sciences sector specializing in innovative oncology drugs and… byPallavi MadhirajuSeptember 19, 2023